ADVANCED OR METASTATIC MERKEL CELL CARCINOMA
Clinical trials for ADVANCED OR METASTATIC MERKEL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED OR METASTATIC MERKEL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED OR METASTATIC MERKEL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to fight hard-to-treat skin cancer
Disease control Recruiting nowThis early-stage trial tests whether adding an experimental drug, IFx-Hu2.0, to the standard immunotherapy pembrolizumab is safe and doable for people with advanced Merkel cell carcinoma that has spread. Nine adults will receive an injection of IFx-Hu2.0 directly into a tumor, fo…
Matched conditions: ADVANCED OR METASTATIC MERKEL CELL CARCINOMA
Phase: PHASE1 • Sponsor: TuHURA Biosciences, Inc. • Aim: Disease control
Last updated May 03, 2026 17:36 UTC
-
New combo therapy shows promise against rare skin cancer
Disease control Recruiting nowThis study tests whether adding an experimental drug (IFx-Hu2.0) to a standard immunotherapy (pembrolizumab) can shrink tumors better than placebo plus pembrolizumab in people with advanced or metastatic Merkel cell carcinoma. About 118 adults with this rare skin cancer will rece…
Matched conditions: ADVANCED OR METASTATIC MERKEL CELL CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: TuHURA Biosciences, Inc. • Aim: Disease control
Last updated Apr 26, 2026 20:02 UTC